On behalf of the members of the Canadian Glaucoma Society (CGS), we, the Executive Committee of the CGS, as well as the CGS MIGS Advocacy Committee, thank you for the opportunity to provide stakeholder feedback on the recent draft of the CADTH report on Micro-Invasive Glaucoma Surgery (MIGS).
Current surgical treatments for glaucoma are aimed at reducing intraocular pressure (IOP) through decreasing aqueous inflow or enhancing of aqueous outflow and thereby reducing the risk of visual field loss.
The first logo for the CGS was conceived in 2003, many years after the founding of the Society, by our first President, Dr Raymond LeBlanc. In consultation with the Executive of the day, it was decided that the logo would honour one of the “founding fathers” of modern enquiry and practice of glaucoma in Canada.
There is broad agreement among Canadian and international glaucoma specialists, based on current evidence and practice patterns, that MIGS do have a role in the glaucoma treatment algorithm and that enough published evidence exists to support access to this category of procedures for Canadian patients.
Although the Canadian Glaucoma Society (CGS) was officially founded in 1989, the origins of the CGS can be traced back to the early 1970s. Fellows of Dr. Stephen Drance, in conjunction with other glaucomatologists, met annually at the Canadian Ophthalmology Society (COS) to present cases and study reports...